Novo Nordisk narrowed its earnings guidance as intensifying competition, pricing pressure and copycat versions of its ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

America's obesity epidemic costs an estimated $173 billion each year. The benefits of covering GLP-1s vastly outweigh the ...

The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar ...

Groundbreaking GLP-1 drugs like Ozempic, Mounjaro and Wegovy are revolutionising weight loss, with studies showing ...

WASHINGTON D.C., DC — Costco now carries medications like Ozempic and Wegovy at a fraction of the cost after partnering with healthcare company Novo Nordisk. Both medications are used for weight loss, ...

In the first hour of "Connections with Evan Dawson" on 10/27/25, our panel of experts explore the pros and cons of using ...

Ozempic, a diabetes drug turned global weight loss trend, is gaining traction in India. Experts warn it's not a miracle fix, ...

Novo Nordisk A/S ( NVO) trimmed its forecast for a fourth time this year on Wednesday, citing lower-than-expected sales of ...

Ensuring GLP-1s are covered by Medicaid in all states would save lives—and not be as costly as some people fear.